The PedsQL™ in type 1 and type 2 diabetes

被引:452
|
作者
Varni, JW
Burwinkle, TM
Jacobs, JR
Gottschalk, M
Kaufman, F
Jones, KL
机构
[1] Texas A&M Univ, Coll Architecture, Dept Landscape Architecture & Urban Planning, College Stn, TX 77843 USA
[2] Texas A&M Univ, Coll Med, College Stn, TX 77843 USA
[3] Childrens Hosp & Hlth Ctr, Ctr Child Hlth Outcomes, San Diego, CA USA
[4] Childrens Hosp & Hlth Ctr, Div Endocrinol, San Diego, CA USA
[5] Univ Calif San Diego, Dept Pediat, Sch Med, San Diego, CA 92103 USA
[6] Childrens Hosp Los Angeles, Div Endocrinol, Los Angeles, CA 90027 USA
[7] Univ So Calif, Sch Med, Dept Pediat, Los Angeles, CA 90033 USA
关键词
D O I
10.2337/diacare.26.3.631
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - The Pediatric Quality of Life Inventory (PedsQL) is a modular instrument designed to measure health-related quality of life (HRQOL) in children and adolescents aged 2-18 years. The PedsQL 4.0 Generic Core Scales are child self-report and parent proxy-report scales developed as the generic core measure to be integrated with the PedsQL disease-specific modules. The PedsQL 3.0 Type I Diabetes Module was designed to measure diabetes-specific HRQOL. RESEARCH DESIGN AND METHODS - The PedsQL Generic Core Scales and Diabetes Module were administered to 300 pediatric patients with type I or type 2 diabetes and 308 parents. RESULTS - internal consistency reliability for the PedsQL Generic Core Total Scale score (alpha = 0.88 child, 0.89 parent-report) and most Diabetes Module scales (average alpha = 0.71 child, 0.77 parent-report) was acceptable for group comparisons. The PedsQL 4.0 distinguished between healthy children and children with diabetes. The Diabetes Module demonstrated inter-correlations with dimensions of generic and diabetes-specific HRQOL. CONCLUSIONS - The results demonstrate the reliability and validity of the PedsQL in diabetes. The PedsQL may be used as an outcome measure for diabetes clinical trials and research.
引用
收藏
页码:631 / 637
页数:7
相关论文
共 50 条
  • [31] Pharmacologic interventions for type 1 and type 2 diabetes
    Fain, James A.
    Miller, David K.
    NURSING CLINICS OF NORTH AMERICA, 2006, 41 (04) : 589 - +
  • [32] Cardiovascular outcomes in type 1 and type 2 diabetes
    Rosengren, Annika
    Dikaiou, Pigi
    DIABETOLOGIA, 2023, 66 (03) : 425 - 437
  • [33] Stereology of the placenta in type 1 and type 2 diabetes
    Higgins, M.
    Felle, P.
    Mooney, E. E.
    Bannigan, J.
    McAuliffe, F. M.
    PLACENTA, 2011, 32 (08) : 564 - 569
  • [34] Lipid disorders in type 1 and type 2 diabetes
    Goldberg, RB
    Capuzzi, D
    CLINICS IN LABORATORY MEDICINE, 2001, 21 (01) : 147 - +
  • [35] Cardiovascular outcomes in type 1 and type 2 diabetes
    Annika Rosengren
    Pigi Dikaiou
    Diabetologia, 2023, 66 : 425 - 437
  • [36] Misdiagnosis of type 1 and type 2 diabetes in adults
    不详
    LANCET REGIONAL HEALTH-EUROPE, 2023, 29
  • [37] A comparison of type 1 and type 2 diabetes in pregnancy
    Durnwald, Celeste
    Franco, Albert
    Landon, Mark
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (06) : S158 - S158
  • [38] Glycemic treatment in type 1 and type 2 diabetes
    Bloomgarden, Zachary T.
    DIABETES CARE, 2006, 29 (11) : 2549 - 2555
  • [39] Anemia in patients with type 1 and type 2 diabetes
    Fischer, H
    Schroeter, W
    Nauck, MA
    DIABETES, 2005, 54 : A204 - A204
  • [40] Exubera® -: Treatment of type 1 and type 2 diabetes
    Cox, SL
    DRUGS OF THE FUTURE, 2004, 29 (12) : 1206 - 1210